We are monitoring the impact of COVID-19 on Europe Histone Deacetylase Inhibitors Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 5288
Share on
Share on

Europe Histone Deacetylase Inhibitors Market By Class (Class I HDACs, Class II HDACs, And Class III HDACs), By Application (Cancer, Central Nervous System Disorders, Other Diseases), By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017-2022)

Pulished: February, 2020
ID: 5288
Pages: 145

The Europe Histone Deacetylase Inhibitors market size was around USD XX billion in 2017. It is expected to grow at a CAGR of XX% to reach USD XX billion by 2022. It captures XX% of the global market share.HDAC is an anticancer agent. It consists of a group of molecules. Chemically speaking these are basically enzymes with N-acetyl lysine amino acid present on a histone. They have a large number of applications in oncology. They are also used in the treatment of solid and haematological malignancies.

Increasing number of people affected by cancer, better funding and savoury government policies for R&D in the cancer treatment field, and high demand for efficient treatment with lower costs are the primary drivers of market growth.Ambiguity in the reimbursement policies is the primary restraint of this market.The market is segmented by class and application. Classification by class entails Class I HDACs, Class II HDACs, and Class III HDACs. Classification by application entails Cancer, Central Nervous System Disorders, and Other Diseases.

Classification by geography entails UK, Spain, Germany, France and others. Europe comes second by market share. It is however anticipated to experience slow growth in the forecast period. UK will lead the market in Europe.

Key players in the market are Merck & Co., Inc., Celgene Corporation, Eisai Pharmaceuticals. Other players in the market include Novartis, Acetylon Pharmaceuticals, Celleron Therapeutics, Envivo Pharmaceuticals and Pfizer, Inc

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Class                              

                                5.1.1 Introduction           

                                5.1.2 Class I HDACs         

                                5.1.3 Class II HDACs        

                                5.1.4 Class III HDACs       

                                5.1.5  Y-o-Y Growth Analysis, By Class    

                                5.1.6  Market Attractiveness Analysis, By Class  

                                5.1.7  Market Share Analysis, By Class    

                5.2 Application                 

                                5.2.1 Introduction           

                                5.2.2 Cancer      

                                5.2.3 Central Nervous System Disorders               

                                5.2.4 Other Diseases      

                                5.2.5 Y-o-Y Growth Analysis, By Application         

                                5.2.6 Market Attractiveness Analysis, By Application       

                                5.2.7 Market Share Analysis, By Application        

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Class

                                                6.1.3.3 By Application

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Class

                                                6.1.4.3 By Application

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Class

                                                6.1.5.3 By Application

                6.2 U.K                 

                6.3 Spain                             

                6.4 Germany                     

                6.5 Italy                               

                6.6 France                          

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Celgene                       

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Acetylon Pharmaceuticals                    

                8.3 Celleron Therapeutics                            

                8.4 Envivo Pharmaceuticals                         

                8.5 Novartis                       

                8.6 Merck & Co.                               

                8.7 Pfizer                            

                8.8 Eisai Pharmaceuticals                             

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms product type and Packaged Containers along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Histone Deacetylase Inhibitors Market By Application, From 2016-2022 ( USD Million )
  2. Europe Cancer Market By Region, From 2016-2022 ( USD Million )
  3. Europe Central Nervous System Disorders Market By Region, From 2016-2022 ( USD Million )
  4. Europe Other Diseases Market By Region, From 2016-2022 ( USD Million )
  5. Europe Histone Deacetylase Inhibitors Market By Class, From 2016-2022 ( USD Million )
  6. Europe Class I HDACs Market By Region, From 2016-2022 ( USD Million )
  7. Europe Class II HDACs Market By Region, From 2016-2022 ( USD Million )
  8. Europe Class III HDACs Market By Region, From 2016-2022 ( USD Million )
  9. U.K. Histone Deacetylase Inhibitors Market By Application, From 2016-2022 ( USD Million )
  10. U.K. Histone Deacetylase Inhibitors Market By Class, From 2016-2022 ( USD Million )
  11. Germany Histone Deacetylase Inhibitors Market By Application, From 2016-2022 ( USD Million )
  12. Germany Histone Deacetylase Inhibitors Market By Class, From 2016-2022 ( USD Million )
  13. France Histone Deacetylase Inhibitors Market By Application, From 2016-2022 ( USD Million )
  14. France Histone Deacetylase Inhibitors Market By Class, From 2016-2022 ( USD Million )
  15. Italy Histone Deacetylase Inhibitors Market By Application, From 2016-2022 ( USD Million )
  16. Italy Histone Deacetylase Inhibitors Market By Class, From 2016-2022 ( USD Million )
  17. Spain Histone Deacetylase Inhibitors Market By Application, From 2016-2022 ( USD Million )
  18. Spain Histone Deacetylase Inhibitors Market By Class, From 2016-2022 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample